Naydenov Jordan G 4

4 · CytoDyn Inc. · Filed Sep 27, 2021

Insider Transaction Report

Form 4

Period: 2021-09-23

CytoDyn Inc.CYDY

Naydenov Jordan G

Director

Transactions

Disposition to Issuer
Warrant (Right to Buy)
2021-09-23−133,334→ 0 total
Exercise: $0.75From: 2018-01-31Exp: 2023-01-31→ Common Stock (133,334 underlying)
Award
Warrant (Right to Buy)
2021-09-23+133,332→ 133,332 total
Exercise: $0.75From: 2021-09-23Exp: 2022-07-26→ Common Stock (133,332 underlying)
Exercise/Conversion
Warrant (Right to Buy)
2021-09-23−133,332→ 0 total
Exercise: $0.75From: 2021-09-23Exp: 2022-07-26→ Common Stock (133,332 underlying)
Exercise/Conversion
Warrant (Right to Buy)
2021-09-23−266,668→ 0 total
Exercise: $0.75From: 2021-09-23Exp: 2023-01-31→ Common Stock (266,668 underlying)
Disposition to Issuer
Warrant (Right to Buy)
2021-09-23−444,444→ 0 total
Exercise: $0.45From: 2019-12-13Exp: 2024-12-13→ Common Stock (444,444 underlying)
Exercise/Conversion
Common Stock
2021-09-23$0.75/sh+266,668$200,001→ 7,990,211 total
Award
Warrant (Right to Buy)
2021-09-23+266,668→ 266,668 total
Exercise: $0.75From: 2021-09-23Exp: 2023-01-31→ Common Stock (266,668 underlying)
Exercise/Conversion
Common Stock
2021-09-23$0.75/sh+133,332$99,999→ 7,723,543 total
Disposition to Issuer
Warrant (Right to Buy)
2021-09-23−66,666→ 0 total
Exercise: $0.75From: 2017-07-26Exp: 2022-07-26→ Common Stock (66,666 underlying)
Exercise/Conversion
Warrant (Right to Buy)
2021-09-23−888,888→ 0 total
Exercise: $0.45From: 2021-09-23Exp: 2024-12-13→ Common Stock (888,888 underlying)
Exercise/Conversion
Common Stock
2021-09-23$0.45/sh+888,888$400,000→ 7,590,211 total
Award
Warrant (Right to Buy)
2021-09-23+888,888→ 888,888 total
Exercise: $0.45From: 2021-09-23Exp: 2024-12-13→ Common Stock (888,888 underlying)

Footnotes (1)

[F1]On September 23, 2021, as an inducement to exercise, the Issuer and the Reporting Person agreed to amend three warrants held by the Reporting Person (the "Warrants") to purchase a total of 644,444 shares of the Issuer's common stock, par value $0.001 per share (the "Common Stock"), pursuant to which twice as many shares could be purchased for double the total original exercise price.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION